Category: Zimmer HoldingsSyndicate content

EU, Zimmer agree to extend review of Biomet merger

November 18, 2014 by Brad Perriello

Zimmer says it agreed with the European Commission to extend the EuroZone review of its pending, $13.4 billion acquisition of cross-town orthopedics rival Biomet.

EU, Zimmer agree to extend review of Biomet merger

Plan for Medtronic-Covidien management structure unveiled | The week in medtech M&A

November 5, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic unveils post-merger management structure; Abbott buys into electrophysiology with $250m Topera acquisition; Zimmer reveals post-Biomet merger plans; Medtronic, Covidien merger expected to close in 2015; Covidien deals Stellarex balloon to Spectranetics for $30m

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Zimmer reveals post-Biomet merger plans

October 31, 2014 by Brad Perriello

Zimmer reveals the management team and business structure it plans to put in place once its $13 billion merger with rival Biomet closes.

Zimmer reveals post-Biomet merger plans

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Zimmer posts Q3 earnings above expectations, narrows guidance

October 23, 2014 by Brad Perriello

Zimmer Holdings says its 3rd-quarter earnings beat expectations and narrows its sales and earnings guidance for the rest of the year.

Zimmer posts Q3 earnings above expectations, narrows guidance

Zimmer's (NYSE:ZMH) 3rd-quarter earnings came in ahead of expectations on strong performances from its core knee and hip implant businesses.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A

October 22, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

More than 2½ years after it spent $21.3 billion on Synthes, Johnson & Johnson continues to take hefty charges on integrating the orthopedics company into its DePuy franchise.

JNJ continues to pay hefty integration charges on Synthes deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Peripherals transition team named in Medtronic, Covidien merger | The week in medtech M&A

October 8, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic, Covidien name peripherals biz transition team; Medtronic is still in on Covidien buyout; The Street cheers changes to the Medtronic, Covidien deal; Zimmer adds Harvard spinout Etex Corp.; EU to extend Zimmer, Biomet probe

Medtronic, Covidien name peripherals biz transition team

October 1, 2014 by Alex Soule

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp